{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-26-011979","form_type":"8-K","ticker":"BLCO","cik":"0001860742","company_name":"Bausch & Lomb Corp","filed_at":"2026-08-06T11:10:22+00:00","discovered_at":"2026-08-06T11:15:03.438163+00:00","generated_at":"2026-08-06T11:15:29.240184+00:00","sec_items":["1.01","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bausch + Lomb appoints four new directors, reaffirms 2026 guidance after Q2 revenue of $1.394B","bullets":["Q2 revenue $1.394B, up 9% reported and 8% constant currency vs Q2 2025; broad-based double-digit growth in Surgical and Pharma.","Cash flow from operations rose to $153M in Q2 from $32M in Q1; adjusted cash flow from operations $161M.","Full-year 2026 guidance reaffirmed: revenue $5.44B–$5.54B, Adj EBITDA (ex-IPR&D) $1.025B–$1.075B.","Board adds Thomas Appio (CEO of Bausch Health), Robert Chersi, Laurence Paul, and Barbara Trebbi; four prior directors resigned.","Resignations not due to disagreement; departing directors receive prorated cash and full RSU vesting; Thomas Ross gets $400K consulting fee."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-26-011979","json":"https://secwatch.observer/filing/0000950103-26-011979.json","markdown":"https://secwatch.observer/filing/0000950103-26-011979.md","text":"https://secwatch.observer/filing/0000950103-26-011979.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860742/000095010326011979/0000950103-26-011979-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860742/000095010326011979/dp251415_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:15:29.240184+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}